Skip to main content
SpringerLink
Log in

ECMO in Myocarditis and Rare Cardiomyopathies

  • Chapter
  • First Online:
ECMO-Extracorporeal Life Support in Adults

  • 5644 Accesses

Abstract

Myocarditis is an inflammatory disease of the myocardium. It is typical of young individuals without significant comorbidities, and it is characterized by unpredictable clinical presentation and evolution to life-threatening arrhythmias and overt cardiogenic shock. This explains why, although representing only a minority of overall indications to ECMO, it is frequently reported in literature as a fulminant disease that requires mechanical support to improve short- and long-term prognosis. Despite its grave presentation and clinical evolution, the overall prognosis is fairly good, in terms of both survival and recovery. ECMO is therefore a valuable asset in this group of diseases, to bridge young and otherwise healthy patients to complete recovery or to transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bowles NE, Ni J, Kearney DL et al (2003) Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42:466–472

    Article  PubMed  Google Scholar 

  2. Pankuweit S, Moll R, Baandrup U et al (2003) Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol 34:497–503

    Article  PubMed  Google Scholar 

  3. Kindermann I, Kindermann M, Kandolf R et al (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639–648

    Article  PubMed  Google Scholar 

  4. Kühl U, Pauschinger M, Seeberg B et al (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965–1970

    Article  PubMed  Google Scholar 

  5. Mason JW, O’Connell JB, Herskowitz A et al (1995) A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333(5):269–275

    Article  CAS  PubMed  Google Scholar 

  6. Maron BJ, Doerer JJ, Haas TS et al (2009) Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 119:1085

    Article  PubMed  Google Scholar 

  7. Lambert EC, Menon VA, Wagner HR et al (1974) Sudden unexpected death from cardiovascular disease in children. A cooperative international study. Am J Cardiol 34:89–92

    Article  CAS  PubMed  Google Scholar 

  8. Stevens PJ, Ground KE (1970) Occurrence and significance of myocarditis in trauma. Aerosp Med 41:776–780

    CAS  PubMed  Google Scholar 

  9. Felker GM, Thompson RE, Hare JM et al (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077–1084

    Article  CAS  PubMed  Google Scholar 

  10. Herskowitz A, Willoughby SB, Baughman KL et al (1992) Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: a report of six cases. Ann Intern Med 116(4):311–313

    Article  CAS  PubMed  Google Scholar 

  11. Halsell JS, Riddle JR, Atwood JE et al (2003) Myopericarditis following smallpox vaccination among vaccinia-naive US military, personnel. JAMA 289:3283–3289

    Article  PubMed  Google Scholar 

  12. Cassimatis DC, Atwood JE, Engler RM et al (2004) Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol 43:1503–1510

    Article  PubMed  Google Scholar 

  13. Frustaci A, Cuoco L, Chimenti C et al (2002) Celiac disease associated with autoimmune myocarditis. Circulation 105:2611–2618

    Article  PubMed  Google Scholar 

  14. Bergelson JM, Cunningham JA, Droguett G et al (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320–1323

    Article  CAS  PubMed  Google Scholar 

  15. Martino TA, Liu P, Sole MJ (1994) Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 74:182–188

    Article  CAS  PubMed  Google Scholar 

  16. Burke AP, Saenger J, Mullick F et al (1991) Hypersensitivity myocarditis. Arch Pathol Lab Med 115:764–769

    CAS  PubMed  Google Scholar 

  17. Fenoglio JJ Jr, McAllister HA Jr, Mullick FG (1981) Drug related myocarditis. I. Hypersensitivity myocarditis. Hum Pathol 12:900–907

    Article  PubMed  Google Scholar 

  18. Cooper LT Jr, Berry GJ, Shabetai R et al (1997) Idiopathic giant-cell myocarditis – natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 336:1860–1866

    Article  PubMed  Google Scholar 

  19. Cooper LT Jr, Hare JM, Tazelaar HD et al (2008) Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 102:1535–1539

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Gavaert S, Van Belleghem Y, Bouchez S et al (2011) Acute and critically ill peripartum cardiomyopathyand “bridge to” therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular device. Crit Care 15:R93

    Article  Google Scholar 

  21. Huang J, Huang S, Chou N et al (2008) Extracorporeal membrane oxygenation rescue for cardiopulmonary collapse secondary to pheochromocytoma: report of three cases. Intensive Care Med 34:1551–1552

    Article  PubMed  Google Scholar 

  22. Banfi C, Juthier F, Ennezat P et al (2012) Central extracorporeal life support in pheochromocytoma crisis. Ann Thorac Surg 93:1303–1305

    Article  PubMed  Google Scholar 

  23. Sheinberg R, Gao W, Wand G et al (2012) A perfect storm: fatality resulting from metoclopramide unmasking a pheochromocytoma and its management. J Cardiothorac Vasc Anesth 26(1):161–165

    Article  PubMed  Google Scholar 

  24. Chao A, Yeh YC, Yen TS et al (2008) Phaeochromocytoma crisis – a rare indication for extracorporeal membrane oxygenation. Anaesthesia 63:86–88

    Article  CAS  PubMed  Google Scholar 

  25. Grinda JM, Bricourt MO, Salvi S et al (2006) Unusual cardiogenic shock due to pheochromocytoma: recovery after bridge-to-bridge (extracorporeal life support and DeBakey ventricular assist device) and right surrenalectomy. J Thorac Cardiovasc Surg 131:913–914

    Article  PubMed  Google Scholar 

  26. Wernly JA, Dietl CA, Tabel CE et al (2011) Extracorporeal membrane oxygenation support improves survival of patients with Hantavirus cardiopulmonary syndrome refractory to medical treatment. Eur J Cardiothorac Surg 40:1334–1340

    Article  PubMed  Google Scholar 

  27. Dietl CA, Wernly JA, Pett SB et al (2008) Extracorporeal membrane oxygenation support improves survival of patients with severe Hantavirus cardiopulmonary syndrome. J Thorac Cardiovasc Surg 135:579–584

    Article  PubMed  Google Scholar 

  28. Theleman KP, Kuiper JJ, Roberts WC (2001) Acute myocarditis (predominately lymphocytic) causing sudden death without heart failure. Am J Cardiol 88:1078–1083

    Article  CAS  PubMed  Google Scholar 

  29. Drory Y, Turetz Y, Hiss Y et al (1991) Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 68:1388–1392

    Article  CAS  PubMed  Google Scholar 

  30. Felker GM, Boehmer JP, Hruban RH et al (2000) Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36:227–232

    Article  CAS  PubMed  Google Scholar 

  31. Friedrich MG, Strohm O, Schulz-Menger J et al (1998) Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 97:1802–1809

    Article  CAS  PubMed  Google Scholar 

  32. Mahrholdt H, Goedecke C, Wagner A et al (2004) Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109:1250–1258

    Article  PubMed  Google Scholar 

  33. Rajagopal SK, Almond CS, Laussen PC et al (2010) Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry. Crit Care Med 38:382–387

    Article  PubMed  Google Scholar 

  34. Mirabel M, Luyt CE, Leprince P et al (2011) Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med 39:1029–1035

    Article  PubMed  Google Scholar 

  35. Hsu KH, Chi NH, Wang CH et al (2011) Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center’s experience. Eur J Cardiothorac Surg 40:682–688

    PubMed  Google Scholar 

  36. Aoyama N, Izumi T, Hiramori K et al (2002) National survey of fulminant myocarditis in Japan. Therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis. Circ J 66:133–144

    Article  PubMed  Google Scholar 

  37. Maejima Y, Yasu T, Kubo N et al (2004) Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device. Circ J 68:829–833

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiac Anesthesia and Intensive Care Unit, San Gerardo Hospital, Via Pergolesi 33, Monza, 20900, Italy

    Barbara Cortinovis, Monica Scanziani & Simona Celotti

  2. Department of Anesthesia and Intensive Care Medicine, University of Milano-Bicocca, Milan, Italy

    Barbara Cortinovis, Monica Scanziani & Simona Celotti

Authors
  1. Barbara Cortinovis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Monica Scanziani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Simona Celotti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara Cortinovis .

Editor information

Editors and Affiliations

  1. Department of Anaesthesia and Intensive Care Medicine, San Gerardo Hospital, Monza (MB), Italy

    Fabio Sangalli

  2. Department of Health Sciences Medicine, University of Milano-Bicocca, San Gerardo Hospital, Monza (MB), Italy

    Nicolò Patroniti

  3. Health Science Departement, Università Milano Bicocca Facoltà Medicina e Chirurgia, Monza (MB), Italy

    Antonio Pesenti

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Italia

About this chapter

Cite this chapter

Cortinovis, B., Scanziani, M., Celotti, S. (2014). ECMO in Myocarditis and Rare Cardiomyopathies. In: Sangalli, F., Patroniti, N., Pesenti, A. (eds) ECMO-Extracorporeal Life Support in Adults. Springer, Milano. https://doi.org/10.1007/978-88-470-5427-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5427-1_12

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5426-4

  • Online ISBN: 978-88-470-5427-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation